Company Terra Pharm Bio-Medical Srl with Fiscal Code 35693392
recorded a turnover of 2024 of
3.470.988,
with a net profit of
32.156
and having an average number of employees of
8.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Terra Pharm Bio-Medical Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
0
1.938.144
3.448.894
2.711.833
2.829.345
2.832.148
3.022.788
3.524.017
3.470.988
Total Income - EUR
-
0
1.943.625
3.450.093
2.711.833
2.830.128
2.833.226
3.025.598
3.588.103
3.573.614
Total Expenses - EUR
-
32.104
1.910.852
3.448.034
2.693.948
2.715.831
2.768.174
2.964.290
3.558.707
3.534.822
Gross Profit/Loss - EUR
-
-32.104
32.773
2.060
17.885
114.297
65.052
61.308
29.396
38.793
Net Profit/Loss - EUR
-
-32.104
26.143
1.600
14.881
97.606
56.640
51.989
24.786
32.156
Employees
-
0
4
6
6
7
7
7
8
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -1.0%, from 3.524.017 euro in the year 2023, to 3.470.988 euro in 2024.
The Net Profit increased by 7.509 euro, from 24.786 euro in 2023, to 32.156 in the last year.
Check the financial reports for the company - Terra Pharm Bio-Medical Srl
Financial Rating - TERRA PHARM BIO-MEDICAL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Terra Pharm Bio-Medical Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Terra Pharm Bio-Medical Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Terra Pharm Bio-Medical Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Terra Pharm Bio-Medical Srl - CUI 35693392
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
6.517
11.847
8.389
6.583
6.240
4.777
12.521
18.225
48.993
Current Assets
-
5.592
50.301
101.189
278.221
114.854
80.880
138.891
96.447
131.055
Inventories
-
0
3.383
749
216.941
3.405
562
1.026
3.237
54.190
Receivables
-
5.117
10.878
72.912
26.800
24.042
11.486
91.307
57.625
42.544
Cash
-
475
36.041
27.528
34.480
87.408
68.832
46.558
35.585
34.321
Shareholders Funds
-
-30.656
4.433
5.952
20.823
103.436
72.666
63.041
35.804
43.112
Social Capital
-
1.447
9.851
9.670
9.588
9.406
9.198
9.226
9.198
9.147
Debts
-
42.765
57.715
103.625
263.981
17.658
12.991
88.372
78.868
138.838
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
131.055 euro in 2024 which includes Inventories of
54.190 euro, Receivables of
42.544 euro and cash availability of
34.321 euro.
The company's Equity was valued at
43.112 euro, while total Liabilities amounted to
138.838 euro.
Equity increased by 7.509 euro, from 35.804 euro in 2023, to 43.112 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Terra Pharm Bio-Medical Srl